Atazanavir Impurity 17(CAS: 98760-08-8)

Atazanavir Impurity 17 (CAS: 98760-08-8) is a known impurity associated with the antiretroviral drug Atazanavir. It is typically identified during pharmaceutical quality control processes and may arise from degradation or synthesis pathways. This compound is not intended for therapeutic use but is relevant in drug development and analytical research for assessing purity and stability.

Atazanavir Impurity 17 (CAS: 98760-08-8) is primarily used in pharmaceutical research to study degradation products and ensure the quality of Atazanavir. It also plays a role in analytical testing for impurity profiling and in the development of drug manufacturing processes to meet regulatory standards like ICH guidelines. Its applications are limited to non-clinical settings.

Atazanavir Impurity 17 (CAS: 98760-08-8) is not intended for human or animal use. However, safety data for this specific impurity is limited. Handling should follow standard laboratory protocols, including use of personal protective equipment (PPE) to minimize exposure. Safety standards are typically governed by regulatory guidelines for pharmaceutical impurities, ensuring controlled use in research and quality assurance.

Atazanavir Impurity 17 (CAS: 98760-08-8) should be stored in a cool, dry place, away from light and moisture. Maintain storage conditions at 2-8°C to ensure stability. Use airtight, sealed containers and avoid exposure to heat or humidity. Proper storage is critical to prevent degradation and maintain the integrity of the compound for analytical purposes.